Orthostatic hypertension: Home blood pressure monitoring for detection and assessment of treatment with doxazosin

Hypertension Research

Volumn 35, Issue 1, 2012, Pages 100-106

  Hoshide, Satoshi ^a   Parati, Gianfranco ^b   Matsui, Yoshio ^a   Shibazaki, Seiichi ^a   Eguchi, Kazuo ^a   Kario, Kazuomi ^a  

^a JICHI MEDICAL UNIVERSITY   (Japan)

^b UNIVERSITY OF MILANO BICOCCA   (Italy)

Author keywords

doxazosin; home blood pressure; orthostatic hypertension; urinary albumin

Indexed keywords

ALBUMIN; ATENOLOL; CREATININE; DOXAZOSIN;

AGED; ANTIHYPERTENSIVE THERAPY; ARTICLE; BEDTIME DOSAGE; BLOOD PRESSURE MONITORING; CLINICAL ASSESSMENT; CONTROLLED STUDY; CREATININE URINE LEVEL; DIASTOLIC BLOOD PRESSURE; DISEASE DURATION; DRUG DOSE INCREASE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NIGHT; ORTHOSTATIC HYPERTENSION; OUTPATIENT; PROTEIN URINE LEVEL; PULSE RATE; SITTING; STANDING; SYSTOLIC BLOOD PRESSURE; TREATMENT DURATION; URINARY EXCRETION;

AGED; AGED, 80 AND OVER; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; BLOOD PRESSURE MONITORING, AMBULATORY; DOXAZOSIN; FEMALE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; TREATMENT OUTCOME;

EID: 84855419771     PISSN: 09169636     EISSN: 13484214     Source Type: Journal    
DOI: 10.1038/hr.2011.156     Document Type: Article

References (30)

1. Fessel J, Robertson D. Orthostatic hypertension: when pressor reflexes overcompensate. Nat Clin Pract Nephrol 2006; 2: 424-431. (Pubitemid 44174534)
2. Lipsitz LA. Orthostatic hypotension in the elderly. N Engl JMed 1989; 321: 952-957.
3. Eguchi K, Kario K, Hoshide S, Hoshide Y, Ishikawa J, Morinari M, Hashimoto T, Shimada K. Greater change of orthostatic blood pressure is related to silent cerebral infarct and cardiac overload in hypertensive subjects. Hypertens Res 2004; 27: 235-241. (Pubitemid 38594394)
4. Hoshide S, Matsui Y, Shibasaki S, Eguchi K, Ishikawa J, Ishikawa S, Kabutoya T, Schwartz JE, Pickering TG, Shimada K, Kario K. Orthostatic hypertension detected by self-measured home blood pressure monitoring: a new cardiovascular risk factor for elderly hypertensives. Hypertens Res 2008; 31: 1509-1516.
5. Kario K, Eguchi K, Hoshide S, Hoshide Y, Umeda Y, Mitsuhashi T, Shimada K. U-curve relationship between orthostatic blood pressure change and silent cerebrovascular disease in elderly hypertensives: orthostatic hypertension as a new cardiovascular risk factor. J Am Coll Cardiol 2002; 40: 133-141. (Pubitemid 34701388)
6. Eigenbrodt ML, Rose KM, Couper DJ, Arnett DK, Smith R, Jones D. Orthostatic hypotension as a risk factor for stroke: the atherosclerosis risk in communities (ARIC) study, 1987-1996. Stroke 2000; 31: 2307-2313.
7. Matsubayashi K, Okumiya K, Wada T, Osaki Y, Fujisawa M, Doi Y, Ozawa T. Postural dysregulation in systolic blood pressure is associated with worsened scoring on neurobehavioral function tests and leukoaraiosis in the older elderly living in a community. Stroke 1997; 28: 2169-2173. (Pubitemid 27497917)
8. Masaki KH, Schatz IJ, Burchfiel CM, Sharp DS, Chiu D, Foley D, Curb JD. Orthostatic hypotension predicts mortality in elderly men: the Honolulu heart program. Circulation 1998; 98: 2290-2295. (Pubitemid 28533848)
9. Ogihara T, Kikuchi K, Matsuoka H, Fujita T, Higaki J, Horiuchi M, Imai Y, Imaizumi T, Ito S, Iwao H, Kario K, Kawano Y, Kim-Mitsuyama S, Kimura G, Matsubara H, Matsuura H, Naruse M, Saito I, Shimada K, Shimamoto K, Suzuki H, Takishita S, Tanahashi N, Tsuchihashi T, Uchiyama M, Ueda S, Ueshima H, Umemura S, Ishimitsu T, Rakugi H. The Japanese society of hypertension guidelines for the management of hypertension (JSH 2009). Hypertens Res 2009; 32: 3-107.
10. Bobrie G, Chatellier G, Genes N, Clerson P, Vaur L, Vaisse B, Menard J, Mallion J-M. Cardiovascular prognosis of 00Masked hypertension00 detected by blood pressure self-measurement in elderly treated hypertensive patients. JAMA 2004; 291: 1342-1349. (Pubitemid 38541649)
11. Little P, Barnett J, Barnsley L, Marjoram J, Fitzgerald-Barron A, Mant D. Comparison of agreement between different measures of blood pressure in primary care and daytime ambulatory blood pressure. BMJ 2002; 325: 254.
12. Isso JL, Sica DA, Black HR. Hypertension Primer, 4th edn. Lippincott Williams & Wilkins: Philadelphia, 2008, pp 450-452.
13. Ishikawa J, Hoshide S, Shibasaki S, Matsui Y, Kabutoya T, Eguchi K, Ishikawa S, Pickering TG, Shimada K, Kario K. The Japan Morning Surge-1 (JMS-1) study: protocol description. Hypertens Res 2006; 29: 153-159.
14. Japanese Society of Hypertension Guidelines Subcommittee for the Management of Hypertension. Guidelines for the management of hypertension for general practitioners. Hypertens Res 2001; 24: 613-634.
15. Kario K, Matsui Y, Shibasaki S, Eguchi K, Ishikawa J, Hoshide S, Ishikawa S, Kabutoya T, Schwartz JE, Pickering TG, Shimada K. An alpha-adrenergic blocker titrated by selfmeasured blood pressure recordings lowered blood pressure and microalbuminuria in patients with morning hypertension: The Japan Morning Surge-1 study. J Hypertens 2008; 26: 1257-1265. (Pubitemid 351670519)
16. Imai Y, Otsuka K, Kawano Y, Shimada K, Hayashi H, Tochikubo O, Miyakawa M, Fukiyama K. Japanese society of hypertension (JSH) guidelines for self-monitoring of blood pressure at home. Hypertens Res 2003; 26: 771-782. (Pubitemid 37406944)
17. Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics 1977; 33: 159-174. (Pubitemid 8054849)
18. Mancia G, Bertinieri G, Grassi G, Parati G, Pomidossi G, Ferrari A, Gregorini L, Zanchetti A. Effects of blood-pressure measurement by the doctor on patient's blood pressure and heart rate. Lancet 1983; 2: 695-698. (Pubitemid 13002515)
19. Parati G, Stergiou GS, Asmar R, Bilo G, de Leeuw P, Imai Y, Kario K, Lurbe E, Manolis A, Mengden T, O'Brien E, Ohkubo T, Padfield P, Palatini P, Pickering T, Redon J, Revera M, Ruilope LM, Shennan A, Staessen JA, Tisler A, Waeber B, Zanchetti A, Mancia G. European society of hypertension guidelines for blood pressure monitoring at home: a summary report of the second international consensus conference on home blood pressure monitoring. J Hypertens 2008; 26: 1505-1526.
20. Ward C, Kenny RA. Reproducibility of orthostatic hypotension in symptomatic elderly. Am J Med 1996; 100: 418-422. (Pubitemid 26115196)
21. Mogensen CE. Microalbuminuria predicts clinical proteinuria and early mortality in maturity-onset diabetes. N Engl J Med 1984; 310: 356-360. (Pubitemid 14179541)
22. Yudkin JS, Forrest RD, Jackson CA. Microalbuminuria as predictor of vascular disease in non-diabetic subjects. Islington diabetes survey. Lancet 1988; 2: 530-533.
23. Gaborieau V, Delarche N, Gosse P. Ambulatory blood pressure monitoring versus selfmeasurement of blood pressure at home: correlation with target organ damage. J Hypertens 2008; 26: 1919-1927.
24. Stergiou GS, Argyraki KK, Moyssakis I, Mastorantonakis SE, Achimastos AD, Karamanos VG, Roussias LG. Home blood pressure is as reliable as ambulatory blood pressure in predicting target-organ damage in hypertension. Am J Hypertens 2007; 20: 616-621. (Pubitemid 46777257)
25. Neumann J, Ligtenberg G, Klein II, Koomans HA, Blankestijn PJ. Sympathetic hyperactivity in chronic kidney disease: pathogenesis, clinical relevance, and treatment. Kidney Int 2004; 65: 1568-1576. (Pubitemid 38591003)
26. Amann K, Koch A, Hofstetter J, Gross ML, Haas C, Orth SR, Ehmke H, Rump LC, Ritz E. Glomerulosclerosis and progression: effect of subantihypertensive doses of alpha and beta blockers. Kidney Int 2001; 60: 1309-1323. (Pubitemid 32962590)
27. Yoshinari M, Wakisaka M, Nakamura U, Yoshioka M, Uchizono Y, Iwase M. Orthostatic hypertension in patients with type 2 diabetes. Diabetes Care 2001; 24: 1783-1786. (Pubitemid 33716482)
28. Taylor SH. Clinical pharmacotherapeutics of doxazosin. Am J Med 1989; 87: 2S-11S. (Pubitemid 19208767)
29. ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group The Antihypertensive Lipid-Lowering Treatment to Prevent Heart Attack Trial. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT). JAMA 2002; 288: 2981-2997.
30. Chapman N, Chang CL, Dahlof B, Sever PS, Wedel H, Poulter NR. Effect of doxazosin gastrointestinal therapeutic system as third-line antihypertensive therapy on blood pressure and lipids in the Anglo-Scandinavian cardiac outcomes trial. Circulation 2008; 118: 42-48.